Antioxidant activity of melatonin in diabetes in relation to the regulation and levels of plasma Cu, Zn, Fe, Mn, and Se in Zucker diabetic fatty rats

Nutrition

Volumn 29, Issue 5, 2013, Pages 785-789

  Navarro Alarcon, Miguel ^a   Ruiz Ojeda, Francisco J ^a   Blanca Herrera, Rosa M ^a   Agil, Ahmad ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Cu, Zn, Fe, Mn, and Se plasma levels; Diabetes; Melatonin treatment; Obesity; Zucker diabetic fatty and lean rats

Indexed keywords

COPPER; IRON; MANGANESE; MELATONIN; REACTIVE OXYGEN METABOLITE; SELENIUM; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COPPER BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; HOMEOSTASIS; IRON BLOOD LEVEL; MALE; MINERAL HOMEOSTASIS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; ZINC BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; COPPER; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; IRON; MALE; MANGANESE; MELATONIN; MINERALS; OBESITY; OXIDATIVE STRESS; RATS; RATS, ZUCKER; SELENIUM; TRACE ELEMENTS; ZINC;

ANIMALIA; RATTUS;

EID: 84876303008     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.11.005     Document Type: Article

References (46)

1. Korkmaz A., Reiter R.J., Tan D.X., Manchester L.C. Melatonin; from pineal gland to healthy foods. Spatula DD 2011, 1:33-36.
2. Reiter R.J., Paredes S.D., Manchester L.C., Tan D.X. Reducing oxidative/nitrosative stress: A newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009, 44:175-200.
3. Dandona P., Ghanim H., Chaudhuri A., Dhindsa S., Kim S.S. Macronutrient intake induces oxidative and inflammatory stress: Potential relevance to atherosclerosis and insulin resistance. Exp Mol Med 2010, 42:245-253.
4. Reiter R.J. Cytoprotective properties of melatonin: presumed association with oxidative damage and aging. Nutrition 1998, 14:692-696.
5. Maldonado M.D., Moreno H., Clavo J.R. Melatonin present in beer contributes to increase the levels of melatonin and antioxidant capacity in the human serum. Clin Nutr 2009, 28:188-191.
6. Bonnefont-Rousselot D., Collin F. Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology 2010, 278:55-67.
7. Rodríguez-Naranjo M.J., Gil-Izquierdo A., Troncoso A.M., Cantos E., Garcia-Parrilla M.C. Melatonin: a new bioactive compound in wine. J Food Comp Anal 2011, 24:603-608.
8. Reiter R.J., Carneiro R.C., Oh C.S. Melatonin in relation to cellular antioxidative defense mechanisms. Horm Metab Res 1997, 29:363-372.
9. López A., Garcia J.A., Escames G., Venegas C., Ortiz F., López L.C., et al. Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res 2009, 46:188-198.
10. Reiter R.J., Manchester L.C., Dun-Xian T. Melatonin in walnuts: influence on levels of melatonin and total antioxidant capacity of blood. Nutrition 2005, 21:920-924.
11. Othman A.I., El-Missiry A., Amer M.A., Arafa M. Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats. Life Sci 2008, 83:563-568.
12. Bertuglia S., Reiter R.J. Melatonin reduces microvascular damage and insulin resistance in hamsters due to chronic intermittent hypoxia. J Pineal Res 2009, 46:307-313.
13. Dayoub J.C., Ortiz F., Lopez L.C., Venegas C., Pino-Zumaquero A., Roda O., et al. Synergisim between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide. J Pineal Res 2011, 51:324-330.
14. Figueroa-Quevedo A., Agil A. Changes in plasma's oxidative stress and antioxidant activity, measured with melatonin levels, and its relationship to newborns from obese and diabetic pregnancies. J Diab Metab 2011, S4:1-10.
15. Kedziora-Kornatowska K., Szewcyk-Golec K., Kozakiewicz M., Pawluk H., Czuczejko J., Kornatowski T., et al. Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J Pineal Res 2009, 46:333-337.
16. García T., Esparza J.L., Nogués M.R., Romeu M., Domingo J.L., Gómez M. Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer's disease after chronic exposure to aluminum. Hippocampus 2010, 20:218-225.
17. Kumar M., Ahmad A., Rawat P., Faheem Khan M., Rasheed N., Gupta P., et al. Antioxidant flavonoid glycosides from Evolvulus alsinoides. Fitoterapia 2010, 81:234-242.
18. Kozirog M., Poliwczak A.R., Duchnowicz P., Koter-Michalak M., Sikora J., Broncel M. Melatonin improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res 2011, 50:261-266.
19. Singh Dhillon K., Singh J., Singh Lyall J. A new horizon into the pathology, etiology and treatment of migraine. Med Hypotheses 2011, 77:147-151.
20. Rodriguez C., Mayo J.C., Sainz R.M., Antolín I., Herrera F., Martín V. Reiter RJl. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004, 36:1-9.
21. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J Pineal Res 2007, 42:28-42.
22. Agil A., Reiter R.J., Jiménez-Aranda A., Ibán-Arias R., Navarro-Alarcón M., Marchal J.A., Adem A., Fernández-Vázquez G. Melatonin ameliorates low-grade inflammation and oxidative stress in young Zucker diabetic fatty rats. J Pineal Res 2012, 10.1111/jpi.12012.
23. Agil A., Rosado I., Ruiz R., Figueroa A., Zen N., Fernández-Vázquez G. Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats. J Pineal Res 2012, 52:203-210.
24. Agil A., Navarro-Alarcón M., Ruiz R., Abuhamadah S., El-Mir M.Y., Fernández Vázquez G. Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats. J Pineal Res 2011, 50:207-212.
25. Shah P.K., Kaul S., Nilsson J., Cercek B. Exploiting the vascular protective effects of high density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation 2001, 104:2376-2383.
26. Nakanishi S., Yamane K., Kamei N., Nohima H., Okubo M., Kohno N. A protective effect of adiponectin against oxidative stress in japanese americans: The association between adiponectin or leptin and urinary isoprostane. Metabolism 2005, 54:194-199.
27. Ozcankaya R., Delibas N. Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. Croat Med J 2002, 43:28-32.
28. Navarro M., Wood R.J. Plasma changes in micronutrients following a multivitamin and mineral supplement in healthy humans. J Amer Coll Nutr 2003, 22:124-132.
29. Navarro-Alarcón M., Reyes-Pérez A., López-García H., Palomares-Bayo M., Olalla-Herrera M., López-Martínez M.C. Longitudinal study of serum zinc and copper levels in hemodialysis patients and their relation to biochemical markers. Biol Trace Elem Res 2006, 113:209-222.
30. Martínez-Peinado M., Nogueras-López F., Arcos-Cebrián A., Agil A., Navarro-Alarcón M. Serum selenium levels in cirrhotic patients are not influenced by the disease severity index. Nutr Res 2010, 30:574-578.
31. Velasco-Reynold C., Navarro-Alarcón M., López-García H., Perez-Valero V., López-Martínez M.C. Total and dialyzable levels of manganese from duplicate meals and influence of other nutrients: estimation of daily dietary intake. Food Chem 2008, 109:113-121.
32. Cheshchevik V.T., Dremza I.K., Lapshina E.A., Zabrodskaya S.V., Kujawa J., Zavodnik I.B. Corrections by melatonin of liver mitochondrial disorders under diabetes and acute intoxication in rats. Cell Biochem Funct 2011, 29:481-488.
33. Cooper G.J.S. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease. Drugs 2011, 71:1281-1320.
34. Monnier V.M. Transition metals redox: reviving an old plot for diabetic vascular disease. J Clin Invest 2001, 107:799-801.
35. Walter R.M.J., Uriu-Hare J.Y., Olin K.L., et al. Copper, zinc, manganese and magnesium status and complications of diabetes mellitus. Diabetes Care 1991, 14:1050-1056.
36. Terrés Martos C, Navarro Alarcón M, Martín-Lagos F, López Ga de La Serrana H, López MC Martínez. Serum zinc and copper concentrations and Zn/Cu ratios in patients with hepatopathies and diabetes. J Trace Elem Med Biol 1998,12:44-49.
37. Ito S., Fujita H., Narita T., et al. Urinary copper excretion in type 2 diabetic patients with nephropathy. Nephron 2001, 88:307-312.
38. Skwarlo-Sonta K. Functional connections between the pineal gland and immune system. Acta Neurbiol Exp (Wars) 1996, 56:341-357.
39. Baltaci A.K., Mogulkoc R., Kul A., Bediz C.S., Ugur A. Opposite effects of zinc and melatonin on thyroid hormones in rats. Toxicology 2004, 195:69-75.
40. Öztürk G., Akbulut K.G., Afrasyap L. Age-related changes in tissue and plasma zinc levels: modulation by exogenously administered melatonin. Experim Aging Res 2008, 34:453-462.
41. Baltaci A.K., Mogulkoc R. Pinealectomy and melatonin administration in rats: their effects on plasma leptin levels and relationship with zinc. Acta Biol Hung 2007, 58:335-343.
42. Maharai D.S., Limson J.L., Daya S. 6-Hydroxymelatonin converts Fe(III) to Fe(II) and reduces iron-induced lipid peroxidation. Life Sci 2003, 12:1367-1375.
43. Lahiri D.K., Chen D., Lahiri P., Rogers J.T., Greig N.H., Bondy S. Melatonin, metals, and gene expression implications in aging and neurodegenerative disorders. Ann N Y Acad Sci 2004, 1035:216-230.
44. Lin A.M., Ho L.T. Melatonin suppresses iron-induced neurodegeneration in rat brain. Free Radical Biol Med 2000, 28:904-911.
45. Watsanuki A., Okatani Y., Ikenoue N., Izumiva C., Kaneda C. Melatonin inhibits oxidative modification of low-density lipoprotein particles in normolipedic post-menopausal women. J Pineal Res 2000, 28:136-142.
46. Reiter R.J., Tan D.X., Maldonado M.D. Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res 2005, 39:215-216.